GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
3.960
-0.020 (-0.50%)
At close: Jan 16, 2026, 4:00 PM EST
3.890
-0.070 (-1.77%)
After-hours: Jan 16, 2026, 6:37 PM EST
GlucoTrack Market Cap
GlucoTrack has a market cap or net worth of $3.61 million as of January 16, 2026. Its market cap has decreased by -39.76% in one year.
Market Cap
3.61M
Enterprise Value
-964.68K
1-Year Change
-39.76%
Ranking
Category
Stock Price
$3.96
Market Cap Chart
Since April 25, 2013, GlucoTrack's market cap has decreased from $34.13M to $3.61M, a decrease of -89.43%. That is a compound annual growth rate of -16.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 3.61M | 2.33% |
| Dec 31, 2025 | 3.52M | -41.13% |
| Dec 31, 2024 | 5.99M | 9.59% |
| Dec 29, 2023 | 5.46M | -74.96% |
| Dec 30, 2022 | 21.82M | -66.12% |
| Dec 31, 2021 | 64.40M | -9.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 938.39B |
| Johnson & Johnson | 526.38B |
| AbbVie | 379.81B |
| UnitedHealth Group | 302.12B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 271.91B |
| Novo Nordisk | 252.12B |